Inogen Inc (INGN) exhibits 52.2% gross margins and -27.0% return on invested capital within Health Care (Industrial Specialties), balanced against a 8.5x enterprise multiple and 4.8% implied options volatility.
Sustained 52.2% gross profitability converts into -10.2% operating margin and -27.0% ROIC, outpacing sector cost of capital.
ROIC: -27.0% // GM: 52.2%YoY revenue trajectory of +5.9% paired with -7.13% free cash flow yield supports self-funded R&D and capital return.
REV YOY: +5.9% // FCF YLD: -7.13%Altman Z-Score of 1.46 and Piotroski F-Score of 4/9 indicate low near-term refinancing stress.
ALTMAN Z: 1.46 // F-SCORE: 4/9Trading at 8.5x trailing P/E (7.9x Fwd P/E) leaves valuation vulnerable if real 10Y TIPS yields spike.
P/E: 8.5x // EV/EBITDA: —Options market prices a ±5.2% implied move with a 0.85 put/call ratio around $7.26 max pain.
IMPL MOVE: ±5.2% // P/C: 0.85Elevated industry capital intensity and customer concentration in Industrial Specialties require continuous execution to defend 7.7% net margins.
NET MARGIN: 7.7% // D/E: 0.45x| FILER | SIDE | $ VALUE |
|---|---|---|
| INSPECT FULL OWNERSHIP LEDGER IN OWN <GO> | ||
| STRIKE / EXP | TYPE | PREMIUM |
|---|---|---|
| INSPECT GEX & CHAIN IN OPT <GO> | ||
Unblur the exact $50,000 delta-adjusted ETF/options hedge ratio for INGN & activate live FRED threshold breach alerts.